ImmuCell Corp
NASDAQ:ICCC
ImmuCell Corp
NASDAQ:ICCC
Price:
4.88 USD
-10.89%
Market Closed
Updated:
May 16, 2024
ImmuCell Corp
Gain/Loss on Disposition of Assets
|
ImmuCell Corp
Gain/Loss on Disposition of Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Gain/Loss on Disposition of Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gain/Loss on Disposition of Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ImmuCell Corp
NASDAQ:ICCC
|
Gain/Loss on Disposition of Assets
-$8.1k
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ImmuCell Corp's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
-8.1k
USD
-8.1k
USD
Based on the financial report for Dec 31, 2023, ImmuCell Corp's Gain/Loss on Disposition of Assets amounts to -8.1k USD.
What is ImmuCell Corp's Gain/Loss on Disposition of Assets growth rate?
Gain/Loss on Disposition of Assets CAGR 3Y
41%
41%
The average annual Gain/Loss on Disposition of Assets growth rates for ImmuCell Corp have been 41% over the past three years .
You don't have any saved screeners yet
